NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $20.9 million in its first quarter.

The Newark, California-based company said it had a loss of 43 cents per share.

The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 67 cents per share.

The biopharmaceutical company posted revenue of $25.7 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $19.3 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News